Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.05, $0.03 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $58.4 million versus the consensus estimate of $60.75 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.